Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI’s rapid growth and its mission-driven advancements in making cancer care faster, safer, and more accessible through breakthrough artificial intelligence technology.
The Deloitte Technology Fast 50 highlights companies across Finland that have demonstrated outstanding growth, innovation, and potential. MVision AI’s recognition is a testament to its dedication to harnessing AI to enhance the quality and precision of radiation therapy, ultimately impacting the lives of patients worldwide.
Dharanipathy Rangaraj, CEO of MVision AI, expressed his pride and excitement: “This ranking is a monumental achievement for MVision AI and a validation of our commitment to transforming cancer care. At MVision AI, we are driven by the vision of a world where no one should face delays in critical care. Our team’s relentless pursuit of excellence, along with the trust of our partners and investors, has propelled us to this position, and I am deeply grateful for their unwavering support. This honor reinforces our determination to continue breaking new ground and expanding access to life-saving treatments.”
The recognition is an exciting milestone for MVision AI and its mission to revolutionize healthcare through innovation. Alongside its fellow honorees, MVision AI is part of a thriving technology ecosystem in Finland, collectively pushing boundaries and redefining possibilities across industries.
MVision AI looks forward to building on this achievement with continued innovation and dedication to making a difference in the lives of patients, caregivers, and healthcare professionals worldwide.
About MVision AI
MVision AI is a leading provider of AI-powered solutions for radiation therapy treatment planning. Our mission is to empower Radiation Oncology professionals with cutting-edge technology to streamline workflows, enhance treatment quality, and facilitate more patient-focused care. With a commitment to innovation and excellence, MVision AI continues to advance cancer care through the power of AI.
Contact Information
Media Contact: Sakthy Edamaruku
Email: sakthy.edamaruku@mvision.ai
MVision AI Headquarters:
Paciuksenkatu 29, 00270,
Helsinki, Finland
